Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Filo Mining Reports Q2 2021 Results

VANCOUVER, BC, August 13, 2021 /CNW/ - Filo Mining Corp. (TSXV: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) ("Filo Mining" or the "Company") is pleased to announce its results for the three and six months ended June 30, 2021.  HIGHLIGHTS AND OUTLOOK 2020/2021 Campaign Discovers New High-Grade Mineralization and Expands the Deposit to the North, East, and at Depth Jamie Beck, President & CEO, commented, “Filo del Sol is quickly evolving into one of the most significant copper-gold-silver discoveries in recent history. The 2020/2021 drill campaign has confirmed both

Elkem ASA - Buyback of shares

Oslo, 13 August 2021 Please see below information about transactions made under the share buyback programme for Elkem ASA. · Date on which the buyback programme was announced: 20 July 2021 · The duration of the buyback programme: 20 July 2021 to 26 September 2021 · Size of the buyback programme: Up to 10,000,000 shares From 7 August 2021 until 13 August 2021, Elkem ASA has purchased a total of 1,622,100 own shares at the Oslo Stock Exchange at an average price of NOK 34.1916 per share. Aggregated overview of transactions per day: Date Aggregated

Last day of trading in BTA in Initiator Pharma A/S

PRESS RELEASE                 13 August 2021 In July 2021, Initiator Pharma A/S (”Initiator Pharma”) conducted a rights issue in which the general public was given the opportunity to subscribe. Through the rights issue, a total of 7,958,628 shares were issued. The rights issue has now been registered at the Danish Business Authority and the last day of trading in BTA (paid for shares) is on the 18[th] of August 2021. The stop date will be on the 20[th] of August 2021.A total of 7,958,628 new shares have been registered at the Danish Business Authority. These are estimated to be

SMART WIRES RECEIVES ORDER OF $15-17 M FROM NATIONAL GRID ELECTRICITY TRANSMISSION FOR EXTENSION OF EXISTING PROJECTS

Smart Wires Technology Ltd. (“Smart Wires”) has received a Purchase Order from National Grid Electricity Transmission (“NGET”), under an existing Framework Agreement between the parties. The order has an approx. value of $15-17 M, and will be delivered to NGET in 2022.NGET is already leveraging Smart Wires’ technology, SmartValve™, to maximise the use of their existing network across five circuits at three substation sites. The order of additional SmartValves builds on the existing SmartValve installations.

#21-271 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Resolutions from Extraordinary General Meeting of Elos Medtech AB (publ) 2021

Elos Medtech held its Extraordinary General Meeting (”EGM”) on 13 August 2021. Due to the ongoing Covid-19 pandemic, the EGM was carried out through postal voting only, without any physical attendance. The EGM took inter alia the following resolutions: Determination of the number of members of the Board The EGM resolved, in accordance with the proposal from the majority shareholder in Elos Medtech AB, TA Associates, through EM Intressenter AB, that for the period of until the end of the next Annual General Meeting, the number of ordinary members of the Board of Directors shall be five

Peptonic Medical AB terminates the distribution agreement with Yuanjia Bio for the Chinese market

Stockholm, August 13[th] 2021. Peptonic Medical (publ) (‘Peptonic’ or ‘the Company’) informs that the distribution agreement with Yuanjia Biotechnology Co., Ltd. concerning VagiVital® AktivGel for the Chinese market has been terminated.The reason for the termination is a payment default where Yuanjia Biotechnology Co., Ltd. has failed to pay Peptonic Medical a total of EUR 406’. Half of the value for an order in November 2020 and subsequent shipment to China and the other half for an order in February 2021 where the goods is still in Finland. As a consequence q2 results will be negatively

Change in HKScan’s Executive Team

HKScan Corporation, Stock Exchange Release, 13 August 2021 at 3.15 p.m. EETChange in HKScan’s Executive Team Anne Mere, EVP Business Unit Baltics and a member of the Group Executive Team, will leave her position. “I would like to thank Anne for her long and valuable contribution to HKScan and the company’s Baltic business. I wish her all the best for the years ahead,” says HKScan’s CEO Tero Hemmilä.  As of 13 August 2021, Juha Ruohola, a Group Executive Team member, has been appointed as the new EVP Business Unit Baltics. In addition to the Baltic business, he will continue to be

At IKEA, Pride and equality are anchored in our culture

World Pride is a global event that promotes LGBT+ inclusion through parades, festivals and cultural activities. This August, it’s being held in Copenhagen (Denmark) and Malmö (Sweden), where IKEA will participate in events to stand up for LGBT+ rights.LGBT+ inclusion is an ongoing commitment and core belief for IKEA, that goes beyond flags and parades. We stand up against hate and discrimination of any kind, and want to help build a world that is inclusive of all sexual orientations and gender identities – a world where nobody feels the need to conceal who they are or who they love.

Read original

Metsä Tissue welcomes new apprentices to its German mills and starts the application round for 2022

Metsä Tissue, a part of Metsä Group, is one of the leading European tissue paper suppliers, and one of the leading greaseproof paper suppliers globally, offers in Germany various training opportunities to attain new talent and to offer young people career opportunities in its sustainable hygiene business. This July-August, twelve new talents are starting their careers at Metsä Tissue.In Metsä Tissue’s Düren, Kreuzau and Raubach mills, around 60 trainees are trained in craft, technology and administration annually. The training courses are practice-oriented and diverse and the learning

Eevia Health Plc – Interim Report Quarter 2 – 2021

The Board and CEO of Eevia Health Plc hereby present the Interim Report for the second quarter 2021, covering the period April 1[st] through June 30[th], 2021. The complete report with tables is attached to this release as a pdf-file. It is also available on the company website at www.eeviahealth.comSignificant events during the second quarter of 2021: · Eevia experienced another reporting period with significant sales growth. Net sales for the second quarter of 2021 increased by over 250% compared to the same period in 2020. Net sales amounted to KEUR 1 491 (KEUR 423) or KEUR 1 369,

Tecnotree Reports Strong Financial Result for H1 of 2021

Tecnotree, the global Digital Business Support Systems (BSS) provider, announced its 2021 second quarter and half-year results. With the growth in all the parameters, the company reported an increase of 16% in net sales and a remarkable growth of 60% in the net profit for H1 2021 as compared to H1 of 2020. Looking ahead, Tecnotree expects to leverage the competitive advantage for sustainable long-term growth and capitalize on new opportunities related to 5G & IoT technology. Consolidated highlights of the half-year result: · Net sales increased to EUR 27.9 million with the growth of

Salmon Evolution ASA: Invitation to presentation of second quarter 2021 results

Salmon Evolution will present its second quarter 2021 results, followed by a Q&A session, on Thursday, August 19, 2021 at 8:00 a.m. CEST. NOTE: Due to the unfortunate COVID-19 situation and the government's recommendation to limit physical meetings, the presentation will be held as a webcast. The webcast will be held by CEO, Håkon André Berg and CFO, Trond Håkon Schaug-Pettersen. The presentation and subsequent Q&A will be held in English. The presentation can be accessed at www.salmonevolution.no, or with the following link: https://streams.eventcdn.net/salmonevolution/q2-h1-

Orkla’s acquisition of Hans Kaspar completed

In its notification of 13 July 2021, it was announced that Orkla has entered into an agreement to purchase the Swiss company Hans Kaspar, thereby strengthening its position in confectionery and ice cream ingredients.The transaction was completed today. Hans Kaspar will be consolidated into Orkla's financial statements as of 1 August 2021. The notification of 13 July 2021 can be found here: https://investors.orkla.com/English/news/ir-news/ir-news-details/2021/Orkla-acquires-Hans-Kaspar-in-Switzerland/default.aspx Orkla is a leading supplier of branded consumer goods and concept

Former footballer kicks back at racism

An ex-footballer championing racial equality in the game has graduated from Staffordshire University with first-class honours.Courtney Pitt started as a youth player at Chelsea before playing professionally for clubs including Coventry City, Portsmouth and Luton Town. Now, he is working as a youth coach to inspire the next generation of players.   After completing a foundation degree at Stafford College, Courtney enrolled on the BSc (Hons) Physical Education and Youth Sport Coaching  degree at Staffordshire

Qred increases number of active customers by 44 %

Qred, market leader within small business financing in the Nordic region, continues to grow and show profitability during the second quarter of 2021. The number of monthly active users amounted to 11,545, which means a growth of +44%. Stockholm, 13 August, 2021 - The second quarter shows that the market for business loans is recovering after being negatively affected by the pandemic for a long time. Qred’s number of active users, i.e. the number of companies that actively used Qred for a loan and / or factoring at the end of the quarter, has increased by 44%.“More and more small

SelectImmune Pharma reports significant patent progress across the project portfolio

Selectimmune Pharma is pleased to announce a continued strengthening of its intellectual property portfolio through a number of recent patent grants.Following extensive research into the treatment of cystitis using interleukin-1 receptor antagonists (IL1-RA), patent protection was sought in Europe, the US and Australia. The US and Australian patent offices granted protection in May of this year and the European Patent Office recently announced acceptance of the patent claims. Grant of the European patent is therefore expected to follow soon.  Selectimmune Pharma continues to seek

SelectImmune Pharma will implement reporting in English

SelectImmune Pharma is extending its presence on the international Pharmaceutical arena, where research & development as well as clinical study results and strategic partnerships are typically reported in English. Hence the company Board of Directors has decided to change the company reporting language to English from 2021/2022 and onwards. The web site will feature parallel documents in English and Swedish, including Annual and quarterly reports and press releases.   For more information, please contact: Catharina Svanborg Chairman of the board SelectImmune Pharma AB

poLight ASA - Invitation to presentation of Q2 2021 results

poLight ASA will release its Q2 2021 results on Friday 20 August 2021 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 08:30 am CEST through live webcast.Please join the Q2 2021 results webcast by clicking here: https://channel.royalcast.com/landingpage/hegnarmedia/20210820_4/ 

Enersense International Plc Half-year report 2021: Positive result and market

Enersense International Plc  Stock Exchange Release 13 August 2021 at 12 p.m. This release is a summary of Enersense International Plc’s January-June 2021 Half-year Financial Report. The complete report is attached to this release as a pdf file. It is also available on the company's website at www.enersense.com/investors.April–June 2021   · Turnover EUR 61.6 million (16.4), +275.2% year-on-year   · EBITDA EUR 5.8 million (1.1), EBITDA margin 9.4% (6.4)  · Operating profit EUR 3.0 million (0.7), profit margin 4.9% (4.4)  · Order backlog EUR 301 million at the end of the

Scandinavian ChemoTech participates in the European Oncology Convention 2021

Mohan Frick will participate and present at the European Oncology Convention 2021 that is held in Birmingham, UK on 15-16 September.The Oncology Convention is dedicated to advancing clinical oncology and life-saving research. The show provides the perfect platform to source the latest innovations and CPD accredited education in preventing, diagnosing, treating, and caring for breast, colorectal, lung and prostate cancer. A CPD accredited seminar programme will run alongside the exhibition, hosted by the leading clinicians and researchers in worldwide cancer prevention, diagnosis,

Norway Royal Salmon (NRS): Invitation to Webcast of Q2 2021 on 23 August 2021 at 8:00 am (CET)

A presentation in Norwegian of NRS's interim report Q2 2021 will be held at 8:00 am (CET) on 23 August 2021. The presentation will be transmitted live in Norwegian on NRS's website www.norwayroyalsalmon.com. Participants will have the opportunity to submit questions online throughout the webcast and a Q&A session will be held at the end of the presentation. A recording of the webcast in Norwegian will be made available on our website www.norwayroyalsalmon.com immediately after the presentation and an English version will be available at 10:00 (CET) the same day. The company's CEO

CS MEDICA A/S approved for listing at Spotlight Stock Market, publishes prospectus

CS MEDICA A/S (”CS MEDICA” or the ”Company”) hereby announces that the Company has been approved for listing at Spotlight Stock Market. The approval is given under the condition that CS MEDICA, a Danish medico cannabis company, raises the minimum limit in the Company's forthcoming issue of units and that the Company obtains a sufficient number of shareholders, in accordance with Spotlight Stock Market’s regulations. Further, CS MEDICA today publishes the prospectus for the upcoming issue of units (shares and free of charge warrants), which amounts to a total of approx. DKK 33.1 million. The

Members of the board of directors and the management team of Pharmacolog exercise all held warrants of series TO1 for approximately SEK 1.47 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.Board members and management in Pharmacolog i Uppsala AB (publ) (”Pharmacolog” or the “Company”) have exercised all of their warrants of series TO1. The subscription period for TO1

There are no items matching the current filter
There are no more items matching the current filter
Back to top